Jagsonpal Pharmaceuticals Limited (BOM:507789)

Market Cap	18.16B
Revenue (ttm)	2.83B
Net Income (ttm)	608.27M
Shares Out	n/a
EPS (ttm)	9.06
PE Ratio	29.85
Forward PE	n/a
Dividend	2.50 (0.92%)
Ex-Dividend Date	Sep 12, 2025

Volume	23,936
Average Volume	83,976
Open	271.35
Previous Close	271.15
Day's Range	261.05 - 275.00
52-Week Range	140.00 - 328.02
Beta	n/a
RSI	58.19
Earnings Date	Aug 6, 2025

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. It serves health care professionals and government institutions. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in New Delhi, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1978
• Employees: 1,025
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507789

Financial Performance

In 2024, Jagsonpal Pharmaceuticals's revenue was 2.69 billion, an increase of 28.76% compared to the previous year's 2.09 billion. Earnings were 553.61 million, an increase of 146.45%.